: Plasmids generated in this study; related to Experimental Procedures Plasmid Cloning mutagenesis on pQE60-CRM1-His (5'-cttttatcagtgatattgttggaTTTagtaggaccagcgaaagtctc-3'/ 5'-gagactttcgctggtcctactAAAtccaacaatatcactgataaaag-3') mutagenesis on pQE60-CRM1-His (5'-caaccaaaaatgtggatataCGTaaagatcctgaaacagtcaagcag-3'/ 5'-ctgcttgactgtttcaggatctttACGtatatccacatttttggttg-3') mutagenesis on pQE60-CRM1-His (5'-ctgaaatacctcaaatatttAAAgctgtttttgaatgcacattg-3'/ 5'-caatgtgcattcaaaaacagcTTTaaatatttgaggtatttcag-3') mutagenesis on pQE60-CRM1-His (5'-ctcagagtttttatcaaactTGGttttgtgatattctccagcata-3'/ 5'-tatgctggagaatatcacaaaaCCAagtttgataaaaactctgag-3') mutagenesis on pQE60-CRM1-His
, cloned into pmRFP-cNLS (Roloff et al., 2013 ) (EcoRI, SalI) pmRFP-Nup214(1859-2090)X1/X2/X3-cNLS synthesized fragments cloned into pmRFP-cNLS (Roloff et al., 2013 ) (EcoRI, SalI) PCR on pmRFP-Nup214(1859-2090)X1/X3-cNLS plasmids (5'-tttCATATGtcaaatacctctaacctatctggaaacag-3'/ 5'-tttCTCGAGtgtggtgttgctgctgctcc-3'), cloned into pET28a (NdeI, XhoI) PCR on pmRFP-Nup214(1859-2090)X2-cNLS plasmid (5'-tttCATATGtcaaatacctctaacctatttggaaacag-3'/ 5'-tttCTCGAGtgtggtgttgctgctgctcc-3'), cloned into pET28a (NdeI, XhoI) PCR on pMal-c2 (5'-tttAGATCTgctgccgaacccgccaaaaacctgg-3'/ 5'-aatGAATTCggccgcggcattagtctgcgcggctgccagggctgcatcgacagtc-3'), cloned into pMal-c2 (BglII, EcoRI) PCR on pmRFP-Nup214(1859-2090)X1/X3-cNLS plasmids Table Legends   Table S1: X-ray 
Supplemental Experimental Procedures

Plasmids
Plasmids coding for CRM1 mutants were obtained by site-directed mutagenesis on the wild type plasmid.
A vector pMal-linkerAAA was cloned from the pMal-c2 vector with appropriate primers to resemble a previously published vector (Smyth et al., 2003) .
Nup214-fragments were amplified by PCR and cloned into pMal-linkerAAA, pGEX-6P1 and pmRFP-cNLS (Roloff et al., 2013) via EcoRI/SalI.
Coding sequences for Nup214 1859-2090 -X1/X2/X3 mutants were synthesized (GeneArt) and cloned into pmRFP-cNLS (Roloff et al., 2013) via EcoRI/SalI. Coding sequences for His- Further details about sequences and primers can be found in Table S3 .
Protein Expression and Purification
Expression and purification of CRM1 (Dolker et al., 2013; Guan et al., 2000) , importin β ( Expression and purification of H. sapiens SPN1 1-291 was analogous to full-length SPN1 (Strasser et al., 2004) .
GST-Nup214 and His-Nup214 fragments were expressed and purified as described before (Roloff et al., 2013) . Glutathione was removed from the eluted GST-Nup214 by buffer exchange into GST prep buffer (50 mM Tris pH 6.8, 300 mM NaCl, 1 mM MgCl 2 , 0.25 mM EDTA, 1 mM DTT, 1 µg/ml each of leupeptin, pepstatin, and aprotinin) with PD-10
Desalting Columns (GE Healthcare). His-Nup214 fragments were additionally purified with a HiLoad 26/60 Superdex 75 prep grade column (GE Healthcare) in His prep buffer (50 mM Tris pH 6.8, 200 mM NaCl, 1 mM MgCl 2 , 10% glycerol, 4 mM β-mercaptoethanol, 0.1 mM PMSF and 1µg/ml each of leupeptin, pepstatin, and aprotinin). The fractions containing the His-Nup214 were determined via SDS-PAGE, pooled and concentrated with 20 ml/5 kDa MWCO Spin-XR concentrators (Corning).
Plasmids coding for MBP Nup214 His -fragments contained a C-terminal His 6 -tag and an Nterminal modified MBP-tag (Smyth et al., 2003) . MBP Nup214 His -fragments were expressed in E. coli BL21 (DE3) codon+ cells in MBP rich medium (1% trypton, 0.5% yeast extract, 0.5% NaCl and 0.2% glucose). Expression was induced with 300 µM IPTG and cells were grown overnight at 18 °C. MBP Nup214 His -fragments were purified in His prep buffer (50 mM Tris pH 6.8, 200 mM NaCl, 1 mM MgCl 2 , 10% glycerol, 4 mM β-mercaptoethanol, 0.1 mM PMSF and 1 µg/ml each of leupeptin, pepstatin, and aprotinin) with a two step protocol using binding to Ni-NTA sepharose followed by binding to amylose resin.
H. sapiens GST-RanBP3 was expressed in E. coli Rosetta II (DE3) cells in 2YT medium
supplemented with ampicillin, chloramphenicol and 2% glucose. Cells were grown at 37 °C to an OD 600 of 0.8. Protein expression was induced by adding 0.5 mM IPTG and cells were grown overnight at 18 °C. Cells were harvested (5000 xg, 20 minutes, 4 °C), washed with PBS and stored at -80 °C until purification. Cells were resuspended in RanBP3 buffer (50 mM Tris pH 8.0, 250 mM NaCl, 2 mM MgCl 2 , 2 mM EDTA, 2mM DTT 1 mM PMSF, 1µg/ml of each leupeptin, pepstatin, and aprotinin) and lyzed using an EmulsiFlex-C3 (Avestin). The clarified lysate (100,000 xg, 30 min, 4 °C) was applied onto glutathion sepharose (GE Healthcare) equilibrated with RanBP3 buffer at 4 °C for 1 hour. Unbound proteins were removed by three washing steps with RanBP3 buffer and one washing step with RanBP3 buffer supplemented with 1 M LiCl. Bound GST-RanBP3 was eluted with RanBP3 buffer containing 15 mM reduced glutathion. GST-RanBP3 was cleaved with PreScission protease (4 °C, overnight) and purified with a Superdex S200 gel filtration column (GE Healthcare) equilibrated in RanBP3 buffer. RanBP3 containing fractions were pooled, concentrated, frozen in liquid nitrogen and stored at -80 °C.
H. sapiens GST-Nup62 was expressed in E. coli BL21 codon+ cells in 2YT medium supplemented with ampicillin. Cells were grown at 37 °C to an OD 600 of 0.7. Protein expression was induced by adding 0.2 mM IPTG and cells were grown overnight at 18 °C.
Cells were harvested (5000 xg, 20 minutes, 4 °C), washed with PBS and stored at -80 °C until purification. Cells were resuspended in Nup62 buffer (50 mM Tris pH 6.8, 300 mM NaCl, 1 mM MgCl 2 , 5% glycerol, 1 mM DTT, 1 µg/ml each of leupeptin, pepstatin, and aprotinin) supplemented with 1.5% sarkosyl and lyzed using an EmulsiFlex-C3 (Avestin). The clarified lysate (100,000 x g, 30 min, 4 °C) was applied onto glutathion sepharose (GE Healthcare) equilibrated with Nup62 buffer at 4 °C for 1 hour. Unbound proteins were removed by three washing steps with Nup62 buffer and bound GST-Nup62 was eluted with Nup62 buffer containing 15 mM reduced glutathion. GST-Nup62 was either changed into Nup62 buffer without glutathione using PD-10 desalting columns (GE Healthcare) or cleaved with PreScission protease (4 °C, overnight). Cleaved Nup62 was purified with a Superdex S75 gel filtration column (GE Healthcare) equilibrated in Nup62 buffer. Nup62 containing fractions were pooled, concentrated, frozen in liquid nitrogen and stored at -80 °C.
Preparation, crystallization and structure determination of the Nup214 export complex
The CRM1-SPN1-RanGTP-MBP Nup214 complex was assembled by mixing the individual components in a 1:3:5:5 molar ratio and subsequently purified using an Superdex 200 gel filtration column (GE Healthcare) in a buffer containing 50 mM NaCl, 20 mM Tris pH 7.5, 2 mM Mg(OAc) 2 and 2 mM DTT. The purified complex was concentrated to 5 mg/ml, frozen in liquid nitrogen and stored at -80 °C. To further improve data quality and reduce scattering contribution from the surrounding liquid (e.g. background noise by the cryo condition) during data collection, the crystals were fished onto micro meshes (MiTeGen) and mounted on beamline 14.3 (BESSY II, Berlin)
equipped with an HC1c crystal humidifier. After complete removal of the liquid surrounding the crystal using a paper wick, the crystals were flash cooled in liquid nitrogen and transferred to beamline 14.1 equipped with a 6M Pilatus detector. Complete datasets of two such treated crystals were collected at beamline 14.1 (BESSY II, Berlin) (Mueller et al., 2012) . Data were processed using XDS and XSCALE (Kabsch, 2010) .
The structure was solved by means of molecular replacement with PHASER (McCoy et al., 2007) using the export complex CRM1-SPN1-RanGTP (PDBid 3gjx) (Monecke et al., 2009) as a starting model. Subsequently, MBP (PDBid 1anf) (Quiocho et al., 1997) 
Identification of protein crosslinks by Mass Spectrometry
Tetrameric complexes containing CRM1, SPN1, RanQ69L 1-180 GTP and a MBP-taggedNup214 1916-2033 -fragment were assembled and purified by gel filtration in PBS. For crosslinking of 1300 pmol of the Nup214-complex (30 min at 25° C in a total volume of 1.5 mL), a BS3:protein ratio of 200:1 was used. In-solution digestion, reduction and alkylation of BS3 crosslinked complexes were performed as described (De et al., 2015) Identification of crosslinks with pLink was performed as published previously (Yang et al., 2012) , with the following parameters: carbamidomethylation of cysteine, fixed; methionine oxidation, variable, FDR=5%. Spectra were searched against a forward and reverse database containing the UNIPROT sequences of the protein complex components.
